4 Things to Know About Racial Disparity in Colorectal Cancer Treatment
Journal of the National Cancer Institute, researchers set out to examine the lower survival rate of black patients with metastatic colorectal cancer.
The researchers examined 9,935 non-Hispanic, white patients and 1,281 black patients with stage IV colorectal cancer.
The study found:
• Black patients had lower rates of consultation with radiation oncology, medical oncology and surgery.
• Black patients seen in consultation received less radiotherapy, chemotherapy and surgery directed at the primary tumor.
• A 15 percent higher risk of mortality in black patients than in white patients.
• Adjustment in treatment eliminated the increased mortality risk in black patients.
The researchers concluded that the results suggest treatment disparity is the cause for inferior survival of black patients with metastatic colorectal cancer and suggested further research into the underlying causes of this inequality.
More Articles on Gastroenterology:
16 Statistics on Irritable Bowel Disease Care
Top 10 Issues in Gastroenterology for 2013
AGA Launches New Guidelines for Crohn's Disease
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- The Future of ACOs for Anesthesiologists
- Healthcare Exchange Traded Funds See Biggest Boom in Years
- FDA Issues Draft Guidance on Off-Label Use Information Dissemination
- Surgical Care Affiliates President & CEO Andrew Hayek Among 2014 Aspen Institute Henry Crown Fellows
- A Look at ASC Valuation Through the Eyes of M&D Companies